Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,130 INR | -1.97% |
|
-1.21% | +58.56% |
Jun. 28 | Orchid Pharma Partners with Cipla to Launch Antibiotic Cefepime- Enmetazobactam in India | CI |
Jun. 06 | Orchid Pharma Gets Indian Regulator's Nod for Enmetazobactam | MT |
Business Summary
Number of employees: 838
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100.0
%
| 5,596 | 100.0 % | 6,659 | 100.0 % | +19.00% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Rest of the World
82.9
%
| 4,795 | 85.7 % | 5,517 | 82.9 % | +15.07% |
India
15.6
%
| 766 | 13.7 % | 1,039 | 15.6 % | +35.60% |
Global
1.5
%
| 35 | 0.6 % | 103 | 1.5 % | +195.23% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 20-03-30 |
Director of Finance/CFO | - | 20-06-28 | |
Kapil Dayya
CMP | Compliance Officer | - | Dec. 15 |
Chellapandi D.
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 07-02-14 | |
S. Mani
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 75 | 20-03-30 | |
Mridul Dhanuka
BRD | Director/Board Member | 42 | 20-03-30 |
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 20-03-30 |
Tanu Singla
BRD | Director/Board Member | 38 | 20-06-28 |
Dharam Vir
BRD | Director/Board Member | 43 | 20-06-28 |
Manoj Goyal
BRD | Director/Board Member | 48 | 20-06-28 |
Arjun Dhanuka
BRD | Director/Board Member | - | 23-10-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 50,719,100 | 14,679,657 ( 28.94 %) | 0 | 28.94 % |
Company contact information
Orchid Pharma Ltd.
SIDCO Industrial Estate Alathur Chengalpattu District
603110, Chennai
+91 44 2821 1000
http://www.orchidpharma.com![address Orchid Pharma Limited(ORCHPHARMA)](https://cdn.zonebourse.com/static/address/9059006.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+58.56% | 686M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- ORCHPHARMA Stock
- Company Orchid Pharma Limited